[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"liver-disease-alcoholic-or-not\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:liver-disease-alcoholic-or-not":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,57],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":33,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":49,"completionDateStruct":51,"leadSponsor":53,"locationsCount":56},"100652550","detecting-liver-fibrosis-in-patients-at-risk-100652550",false,"NCT07775638","Detecting Liver Fibrosis in Patients At-risk","STELIR","Inclusion Criteria:\n\n* Age 40 to 70 years at the time of inclusion\n* At least one of the following risk factors: Overweight or obesity, type 2 diabetes mellitus, risky or harmful alcohol consumption\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Inability to give informed consent\n* Individuals outside the defined age range\n* Other conditions precluding participation based on investigator assessment","ALL","40 Years","70 Years",{"count":20,"type":21},1200,"ESTIMATED","20 Years","OBSERVATIONAL","The project will establish a research cohort (called STELIR; STEatotisk Liver-risk In Rogaland) based on a biobank with an associated health register. The purpose is to collect, store and analyze biological material and clinical data from people at risk of steatotic liver disease (fatty liver disease). The research cohort will consist of individuals who agree to participate and will be followed over many years with planned examinations\u002Ftests at baseline, after 2 years, after 5 years and every 5 years thereafter. The STELIR cohort consists of individuals between 40 and 70 years of age who have one or more of the following risk factors: Obesity, type 2 diabetes or hazardous or harmful alcohol consumption.\n\nThe biological material and clinical data collected will be stored and used for research on liver-related disease risk, diagnostics and treatment.",[26,27,28,29,30,31,32],"Fatty Liver","NAFLD - Non-Alcoholic Fatty Liver Disease","Nash","MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)","Biomarker in Early Diagnosis","Liver Disease (Alcoholic or Not)","Cirrhoses, Liver",[34,35,36,37,38,39,40,41,42,43],"Primary care","General practice","early detection","risk stratification","case finding","Clinical prediction tools","Biomarkers","Non-invasive tests","Liver enzymes","Fibrosis assessment","NOT_YET_RECRUITING","2026-08-19",{"date":47,"type":48},"2026-08-20","ACTUAL",{"date":50,"type":21},"2026-08",{"date":52,"type":21},"2070-12-31",{"name":54,"class":55},"Helse Stavanger HF","OTHER_GOV",1,{"id":58,"slug":59,"hasResults":11,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":11,"sex":16,"minAge":65,"maxAge":4,"enrollmentInfo":66,"targetDuration":68,"studyType":23,"phases":4,"briefSummary":69,"conditions":70,"keywords":75,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":56},"100608847","observational-study-for-the-characterisation-of-patients-affected-by-any-type-of-diabetes-and-endocrine-disorders-100608847","NCT07206875","Observational Study for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine Disorders","Retrospective and Prospective Observational Registry for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine-metabolic Disorders","DiabRegistry","Inclusion Criteria:\n\n* Age ≥18 years\n* Outpatient Diabetes Unit patient\n* Ability to give informed consent\n\nDiagnosis of at least one of the following:\n\n* Metabolic disease, defined as BMI ≥25 Kg\u002Fm2\n* Type 1 or type 2 diabetes mellitus\n* Gestational diabetes\n* Monogenic diabetes (MODY)\n* Other types of diabetes or dysglycemia\n* Dyslipidemia\n* Arterial hypertension\n* Steatosis liver disease (SLD)\n\nExclusion Criteria:\n\n* Age \\\u003C18 years\n* Deny participation at the study\n* Recruitment in an interventional protocol\n* Patients with missing significant data","18 Years",{"count":67,"type":21},10000,"10 Years","The main objective of this retrospective and prospective observational register is to identify anthropometric, clinical, laboratory and\u002For instrumental markers of disease severity and activity in patients suffering from diabetes, endocrine-metabolic disorders, rare diseases in order to improve their diagnosis, monitoring and treatment processes. The Registry is monocentric, observational prospective and retrospective. No additional procedures to those of normal clinical practice are planned, and neither diagnostic approaches nor experimental drugs\u002Fprescriptions will be applied. The data under study (demographic, anthropometric, clinical and care characteristics) will be collected as part of outpatient visits of the Diabetes Outpatient Clinic or admission to Diabetes Day Hospital.\n\nIn case of outpatients, the observation will start at the diagnosis or during the first outpatient visit and will end with the last outpatient visit performed within the total time foreseen for the duration of the study.\n\nThe study will start once the regulatory authorizations are completed, and is expected to last at least 10 years with the possibility of extension",[71,72,73,74,31],"Diabetes","Metabolic Disorders","Arterial Hypertension","Dyslipidemia",[76,77,78,79],"diebetes","metabolic disorders","endocrine disorders","observational study","2025-10-01",{"date":82,"type":48},"2025-10-03",{"date":84,"type":21},"2025-11",{"date":86,"type":21},"2035-11",{"name":88,"class":89},"IRCCS San Raffaele","OTHER"]